Daiichi will seek up to $2.3bn for Ranbaxy

Japanese pharmaceutical group Daiichi Sankyo may borrow up to $2.3bn to finance its purchase of a majority stake in Ranbaxy Laboratories, India’s biggest generic drug maker, EuroWeek has learned.